Praetego
Durham
About Praetego
Praetego is a pharmaceutical company focused on addressing serious diabetic complications. The company's novel and proprietary small molecule candidates target a common pathway in disease progression leading to serious complications. Praetego is headquartered in Durham, North Carolina.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.9M
- Funding stage: Seed
- Last round: Grant (Mar 2023)
- Website: praetego.com
- Phone: 919-610-5950
Industries & Categories
Health Care, Health Diagnostics, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/praetego-10879 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.